ARCHIVES

In Brief: ASCO Letter To Clinton Urges support For Trials; Senator Praises NCI, Bristol; Berlin Back A NCI

This article is from The Cancer Letter archive.

Vol. 19 No. 03 | January 15, 1993

Download PDF Visit The Full Archive

Related Articles

Pitt Criticizes NCI Stance On Repayment For Fraud Trials

September 9, 1994

FDA Committee Can’t Find “Reasonable” Evidence Alkylating Agent Clinical Use Is Carcinogenic

September 10, 1976

Lung Cancer Size May Not Indicate Severity Of Disease

March 29, 2002

Celgene Begins Two Studies With Hoffmann-La Roche.

June 29, 2001

Tumor Cells In Blood May Indicate Aggressive Cancer

April 25, 2003

Clinical Study Section’s Workload Up 50 Percent, Evidence That More Investigators Submitting R01s

January 17, 1992